Cited by

• The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation.

  de Boer EC, Thielen AJ, Langereis JD, Kamp A, Brouwer MC, Oskam N, Jongsma ML, Baral AJ, Spaapen RM, Zeerleder S, Vidarsson G, Rispens T, Wouters D, Pouw RB, Jongerius I. de Boer EC, et al. Clin Transl Immunology. 2023 Jan 27;12(1):e1436. doi: 10.1002/cti2.1436. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36721662 Free PMC article.
• Kidney diseases.

  Daina E, Cortinovis M, Remuzzi G. Daina E, et al. Immunol Rev. 2023 Jan;313(1):239-261. doi: 10.1111/imr.13167. Epub 2022 Nov 12. Immunol Rev. 2023. PMID: 36369988 Free PMC article. Review.
• Low-molecular weight inhibitors of the alternative complement pathway.

  Schubart A, Flohr S, Junt T, Eder J. Schubart A, et al. Immunol Rev. 2023 Jan;313(1):339-357. doi: 10.1111/imr.13143. Epub 2022 Oct 11. Immunol Rev. 2023. PMID: 36217774 Free PMC article. Review.
• Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases.

  Rodríguez de Córdoba S. Rodríguez de Córdoba S. Immunol Rev. 2023 Jan;313(1):71-90. doi: 10.1111/imr.13131. Epub 2022 Sep 11. Immunol Rev. 2023. PMID: 36089777 Free PMC article. Review.
• Possible association of 16p11.2 copy number variation with altered lymphocyte and neutrophil counts.

  Giannuzzi G, Chatron N, Mannik K, Auwerx C, Pradervand S, Willemin G, Hoekzema K, Nuttle X, Chrast J, Sadler MC, Porcu E; 16p11.2 Consortium; Herault Y, Isidor B, Gilbert-Dussardier B, Eichler EE, Kutalik Z, Reymond A. Giannuzzi G, et al. NPJ Genom Med. 2022 Jun 17;7(1):38. doi: 10.1038/s41525-022-00308-x. NPJ Genom Med. 2022. PMID: 35715439 Free PMC article.